Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H HENDERSON

Showing results (451-460 of 547) with videos related to

Pageof 55
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Thoracic Cancer|September 19, 2017
Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparisonRomaine C Nichols, Soon H Huh, Randal H Henderson, et al.
Environmental Science & Technology|March 23, 2022
Global Emissions of Hydrogen Chloride and Particulate Chloride from Continental SourcesBingqing Zhang, Huizhong Shen, Xiao Yun, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Elementa (Washington, D.C.)|October 27, 2018
Scientific assessment of background ozone over the U.S.: Implications for air quality managementDaniel A Jaff, Owen R Cooper, Arlene M Fiore, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
International Journal of Particle Therapy|February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate CancerWilliam M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Technology in Cancer Research & Treatment|July 7, 2011
Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancerR C Nichols, S H Huh, B S Hoppe, et al.
Pageof 55

Showing results (451-460 of 547) with videos related to

Sort By:
Pageof 55
International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancerNancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Thoracic Cancer|September 19, 2017
Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparisonRomaine C Nichols, Soon H Huh, Randal H Henderson, et al.
Environmental Science & Technology|March 23, 2022
Global Emissions of Hydrogen Chloride and Particulate Chloride from Continental SourcesBingqing Zhang, Huizhong Shen, Xiao Yun, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Elementa (Washington, D.C.)|October 27, 2018
Scientific assessment of background ozone over the U.S.: Implications for air quality managementDaniel A Jaff, Owen R Cooper, Arlene M Fiore, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
International Journal of Particle Therapy|February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate CancerWilliam M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Technology in Cancer Research & Treatment|July 7, 2011
Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancerR C Nichols, S H Huh, B S Hoppe, et al.
Pageof 55